home All News open_in_new Full Article

Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs

Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.


today 7 d. ago attach_file Economics

attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics


ID: 3916674040
Add Watch Country

arrow_drop_down